Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HMBD-002 |
Trade Name | |
Synonyms | HMBD002|HMBD 002 |
Drug Descriptions |
HMBD-002 is an antibody that targets VISTA (VSIR; PD1H), potentially resulting in relief of immunosuppression and reduced tumor growth (J Clin Oncol 39:15_suppl, e14569). |
DrugClasses | VSIR Antibody 6 |
CAS Registry Number | NA |
NCIT ID | C185122 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HMBD-002 | HMBD-002 | 0 | 1 |
HMBD-002 + Pembrolizumab | HMBD-002 Pembrolizumab | 0 | 1 |